CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Transcatheter Aortic Valve Replacementdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05171712
NCT05171712N/ACompleted
CompareCT.gov

Portico and Navitor India Clinical Trial

Abbott Medical Devices·interventional·Posted Dec 29, 2021·Updated Apr 15, 2026

In Brief

A clinical study evaluating Transcatheter Aortic Valve Replacement for Aortic Valve Stenosis and 3 related conditions. Completed, enrolled 30 participants across 6 sites.

Detailed Summary

The objective of this clinical trial is to collect data on procedural safety and device performance of the Portico and Navitor devices and FlexNav delivery system to treat patients with severe aortic stenosis in the Indian population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Valve Stenosis, Aortic Valve Failure, Aortic Insufficiency, Aortic Stenosis
CountriesIndia
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedDec 29, 2021
Enrollment StartMay 6, 2022
Primary CompletionDec 21, 2024
Study CompletionJan 28, 2025
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 4.5 years ago

Interventions

Transcatheter Aortic Valve Replacementdevice

Transcatheter Aortic Valve Replacement for the treatment of patients with severe aortic stenosis